openPR Logo
Press release

Rising incidences of CVD is accelerating the Global Myocardial Infarction Treatment Market | Market Opportunities and Forecast, 2018-2023 | Major Companies: AstraZeneca PLC, Merck KGaA, Johnson & Johnson, Pfizer, Inc., Novartis International AG, GlaxoSmit

03-13-2019 12:22 PM CET | Health & Medicine

Press release from: Orion Market Research

Orion Market Research

Orion Market Research

Orion Market Research (OMR) recently published a market research report on the global myocardial infarction treatment market. According to OMR analysis, the global myocardial infarction treatment market is estimated to grow at a significant CAGR during the forecast period (2018-2023). The crucial factors contributing to the growth of the global myocardial infarction treatment market include rising incidence rate of CVD (cardiovascular disease) and intake of high-level sugary food, which significantly increased the prevalence of CADs (coronary artery diseases). Moreover, the shift towards sedentary lifestyle and faulty dietary habits coupled with lack of physical activity are some other factors fueling the growth of the market. However, the high cost of myocardial infarction treatment and delay in certification and approval for heart treatment are some factors restraining the growth of the market.

A full report of global myocardial infarction treatment market is available at https://www.omrglobal.com/industry-reports/myocardial-infarction-treatment-market/

Furthermore, the global myocardial infarction treatment market is segmented on the basis of type, device, diagnosis, treatment and end-users. The report provides detailed & insightful chapters which include market overview, key findings, strategic recommendations, market estimations, market determinants, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

Market Segmentation

1. Global Myocardial Infarction Treatment Market by Type
• ST-Segment Elevation Myocardial Infarction (STEMI) Heart Attacks
• Non-ST Segment Elevation Myocardial Infarction (NSTEMI) Heart Attacks
• Silent Heart Attacks

2. Global Myocardial Infarction Treatment Market by Device
• Left Ventricular Assist Device
• Pacemaker
• Implantable Cardioverter Defibrillator
• Others (Aspiration-Based Catheters)

3. Global Myocardial Infarction Treatment Market by Diagnosis
• Electrocardiography (ECG)
• Chest X-Ray
• Computed Tomography (CT Scan)
• Echocardiography
• Others (Blood Test)

4. Global Myocardial Infarction Treatment Market by Treatment
• Medication
o Analgesics
o Thrombolytic
o Antiplatelet Agents
o Glycoprotein IIb/IIIa Inhibitors
o Others (Adrenergic Blockers)
• Surgery
o Angioplasty
o Bypass Surgery
o Heart Transplant
5. Global Myocardial Infarction Treatment Market by End-Users
• Hospital & Clinics
• Ambulatory Surgical Centers
• Research Institutes

Regions Covered

• North America (the US and Canada)
• Europe (UK, Germany, France, Spain, and Italy)
• Asia-Pacific (China, India, South Korea, and Japan)
• Rest of the World (Middle East & Africa and Latin America)

Company Profiles

• advanceCOR GmbH
• Anthera Pharmaceuticals, Inc.
• AstraZeneca PLC
• Athersys, Inc.
• Bayer AG
• BioVascular, Inc.
• Boehringer Ingelheim International GmbH
• BRISTOL-MYERS SQUIBB Co.
• Caladrius Biosciences, Inc.
• Capricor Therapeutics, Inc.
• CSL Behring
• GlaxoSmithKline PLC
• GNT Pharma Co., Ltd
• Johnson & Johnson
• Merck KGaA
• Mesoblast Ltd.
• Mylan N.V.
• NeuroVive Pharmaceutical AB
• Novartis International AG
• Osiris Therapeutics, Inc.
• Pfizer, Inc.
• PledPharma AB
• Portola Pharmaceuticals, Inc.
• Sandoz International GmbH
• Sanofi SA
• Teva Pharmaceutical Industries Ltd.
• Ventrix, Inc.

For related reports please visit https://www.omrglobal.com/reports-category/medical-devices/

For more update follow LinkedIn https://www.linkedin.com/company/omr-global-research/

About Orion Market Research

Orion Market Research (OMR) a research company known for its crisp and concise reports. The company is equipped with an experienced team and young brigade of analysts. The company aims to provide business insights for decision making to the global clients and offers quality syndicated research reports, customized research reports, Company profiling, consulting and other research-based services. OMR provide global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provide a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Contact us

Orion Market Research Pvt. Ltd.
Anurag Tiwari
Email: info@omrglobal.com
India: +91 7803040404
Global:+1 6467557667
Indore-India-452010
Web: www.omrglobal.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Rising incidences of CVD is accelerating the Global Myocardial Infarction Treatment Market | Market Opportunities and Forecast, 2018-2023 | Major Companies: AstraZeneca PLC, Merck KGaA, Johnson & Johnson, Pfizer, Inc., Novartis International AG, GlaxoSmit here

News-ID: 1651418 • Views: …

More Releases from Orion Market Research

Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sustainability Preferences
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…
Railway Management System Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033. Railway Management System Market Overview The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033. Monocalcium Phosphate Market Overview Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033. Automotive Lubricants Market Overview The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…

All 5 Releases


More Releases for Myocardial

Driving Myocardial Infarction Market Growth in 2025: The Role of Increasing Numb …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Myocardial Infarction Market Size Growth Forecast: What to Expect by 2025? Over the past few years, there has been a significant rise in the size of the myocardial infarction market. It is projected to expand from $2.05 billion in 2024 to $2.2 billion in 2025, exhibiting a compound annual…
Diabetes Epidemic Fuels Myocardial Ischemia Market Growth: An Emerging Driver Tr …
The Myocardial Ischemia Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Myocardial Ischemia Market? The myocardial ischemia market has grown strongly. It will grow from $0.79 billion in 2024 to $0.85 billion in 2025 at a CAGR of 7.3%.…
Transforming the Myocardial Ischemia Market in 2025: Diabetes Epidemic Fuels Myo …
What Is the Expected Size and Growth Rate of the Myocardial Ischemia Market? The market size for myocardial ischemia has demonstrated considerable growth over the last few years. There's a predicted growth from $0.79 billion in 2024 to $0.85 billion in 2025, with a compound annual growth rate (CAGR) of 7.3%. The substantial growth during the historical period can be credited to the use of telemedicine and remote monitoring, the discovery…
Myocardial Infarction Treatment Market Growth and Insights 2024
"The Business Research Company recently released a comprehensive report on the Global Myocardial Infarction Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Myocardial Infarction Drugs Market
According to a new report published by Allied Market Research, titled, "Myocardial Infarction Drugs Market by Product Type (Analgesics, Antiplatelet Agents, Vasodilators, Thrombolytics, Anti-Thrombotic Agents, Glycoprotein IIb/IIIa Inhibitors, Î' Adrenergic Blockers, Angiotensin Receptor Blockers, and Angiotensin Converting Enzyme Inhibitors) and by Distribution Channel (Hospital Pharmacies, Hospitals, Drug Stores, and Online Drug Stores) - Global Opportunity Analysis and Industry Forecast, 2019-2026". The Global market size of Myocardial Infarction Drugs Market was $XX…
Myocardial Ischemia - Pipeline Review, H1 2017 - Pharmaceutical Report
Lack of blood flow and oxygen to the heart muscle lead to cardiac ischemia, also called myocardial ischemia. The signs and symptoms may include chest pain, typically on the left side of the body (angina pectoris), neck or jaw pain, shoulder or arm pain, clammy skin, shortness of breath and nausea and vomiting. Myocardial ischemia can be caused by conditions such as coronary artery disease (atherosclerosis), blood clot, coronary spasm…